Home/Pipeline/ENL‑101

ENL‑101

Obesity‑related inflammation

PreclinicalActive

Key Facts

Indication
Obesity‑related inflammation
Phase
Preclinical
Status
Active
Company

About Enlila

Biotech startup translating Harvard metabolic research into therapies to extend health span and treat age‑related diseases.

View full company profile